In conclusion, our study provides new evidence that CRNDE contributes to leukemogenesis as an oncogenic lncRNA, regulating myeloid differentiation and cell proliferation in APL and NPM1-mutant AML. The gene discussed is NPM1; the disease is acute promyelocytic leukemia.